Events

Future Tech Week 2019

When
SEP ’19
Sun
22
SEP ’19
Sat
28

This was 7 years ago

Location

<p>On and offline</p>

Programmes
  • FET
  • EIC Pilot

The Future Tech Week is organised by EIC Pathfinder FET team of the European Commission in collaboration with the FETFX project. The Future Tech Week aims at raising visibility and awareness around visionary, high-risk and long-term impact research funded by the European Commission under the FET programme, including the EIC Pathfinder as a driver for future breakthrough innovation.

How to participate in the Future Tech Week:

  • Submit your event:
    Organise an event during the Future Tech week to share your futuristic FET vision with like-minded researchers, policy-makers and potential investors via webinars, conferences, workshops, exhibitions, open labs and more! Submission is open until Aug 31. More info on how to submit your idea: http://futuretechweek.fetfx.eu/submit-your-event/
  • Post on the Future Board:
    Explore or share interesting podcasts, articles, videos or picture. Use the #EICFTW hashtag or post them on the Future Board such that your creative side can be featured. You can even compose a FET-related poem or song while you’re at it! The Future Board will be shown during the European Research & Innovation Days. More info on the Future Board: http://futuretechweek.fetfx.eu/future-board/

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Event calendar

  • Joint Research Center
  • Defence

Annual Research Conference 2026: Defence and economic security for a stronger and more independent Europe

NOV
Thu
12

The Annual Research Conference (ARC) bridges academic research and European policymaking, bringing research findings directly to the European Commission. Organised jointly by the Directorate-General for Economic and Financial Affairs (DG ECFIN) and the Joint Research Centre (JRC), the ARC addresses a different topic each year to inform...

Read more
  • Defence
  • EDF
  • NATO-EDA
  • DIRS

Control of strategic goods: Basic training dual-use goods

NOV
Thu
12

Attendees can expect to gain insights into regulations and best practices on dual-use goods relevant to their sectors. Two online sessions of this basic training on dual-use goods are planned on 26 February and 12 November 2026 from 9:30 to 11:45. One physical session is planned on 10 June in the offices of the Strategic Goods Control Unit...

Read more
  • Horizon Europe
  • HorizonEU L+F

Lump Sum Funding in Horizon Europe

NOV
Thu
12

The European Commission is organising a YouTube webinar about Lump Sum Funding in Horizon Europe (HEU) "Lump Sum Funding in HEU: How does it work? How to write a proposal?", including sharing of practical experiences. The link to the programme and the webinar can be found here. No prior registration is needed. You can also go...

Read more
  • Horizon Europe
  • HorizonEU L+F

EU - Webinar: IP & Open Science

NOV
Thu
12

This webinar targets early career researchers and looks at the basics of intellectual property and open science. It aims to show how IP rules and open science practices can work together, and explains that open access does not remove IP considerations or automatically allow commercial use. The session is organised by the European Innovation Council and SMEs Executive Agency through the European IP Helpdesk.

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.